DiDBiT-TMT: A Novel Method to Quantify Changes in the Proteomic Landscape Induced by Neural Plasticity
Journal of Proteome Research · 2024
DOI: 10.1021/acs.jproteome.4c00180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Mariam Gamaleldin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Danish Research Institute of Translational Neuroscience DANDRITE-Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus C 8000, De…. Hauptthemen laut MEDLINE: Proteomics, Norepinephrine, Long-Term Potentiation, Neuronal Plasticity. Die Arbeit nennt 53 Literaturangaben. Gefördert von: European Research Council, Danmarks Grundforskningsfond, Danmarks Frie Forskningsfond.
Abstract (Originalsprache)
Direct detection of biotinylated proteins (DiDBiT) is a proteomic method that can enrich and detect newly synthesized proteins (NSPs) labeled with bio-orthogonal amino acids with 20-fold improved detectability compared to conventional methods. However, DiDBiT has currently been used to compare only two conditions per experiment. Here, we present DiDBiT-TMT, a method that can be used to quantify NSPs across many conditions and replicates in the same experiment by combining isobaric tandem mass tagging (TMT) with DiDBiT. We applied DiDBiT-TMT to brain slices to determine changes in the de novo proteome that occur after inducing chemical long-term potentiation (cLTP) or treatment with the neuromodulator norepinephrine. We successfully demonstrated DiDBiT-TMT's capacity to quantitatively compare up to 9 samples in parallel. We showed that there is a minimal overlap among NSPs that are differentially expressed in cLTP-treated organotypic brain slices, norepinephrine-treated organotypic brain slices, and organotypic slices undergoing combinatorial treatment with norepinephrine and cLTP. Our results point to the possible divergence of the molecular mechanisms underlying these treatments and showcase the applicability of DiDBiT-TMT for studying neurobiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Danish Research Institute of Translational Neuroscience DANDRITE-Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus C 8000, Denmark.
- Department of Molecular Biology and Genetics, Aarhus C 8000, Denmark.
- School of Biotechnology, Nile University, Giza 12588, Egypt.
- Departments of Molecular Medicine and Neurobiology, the Scripps Research Institute, La Jolla 92037, California, United States.
- The Danish National Research Foundation Center of Excellence PROMEMO, Aarhus University, Aarhus C 8000, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark.
ORCID-Profile: Mariam Gamaleldin, Nam-Kyung Yu, Jolene K Diedrich, Daniel B McClatchy, John R Yates
Förderung
- European Research Council
- Danmarks Grundforskningsfond
- Danmarks Frie Forskningsfond
- National Institute on Aging
- National Institute of Mental Health
- Danish Research Institute of Translational Neuroscience, Aarhus University
Zitieren
APA
Gamaleldin, M., Yu, N. K., Diedrich, J. K., Ma, Y., Wienand, A., McClatchy, D. B., Nykjaer, A., Nabavi, S., & Yates, J. R. (2024). DiDBiT-TMT: A Novel Method to Quantify Changes in the Proteomic Landscape Induced by Neural Plasticity. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00180
Vancouver
Gamaleldin M, Yu NK, Diedrich JK, Ma Y, Wienand A, McClatchy DB, et al. DiDBiT-TMT: A Novel Method to Quantify Changes in the Proteomic Landscape Induced by Neural Plasticity. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00180
BibTeX
@article{Gamaleldin2024,
author = {Gamaleldin, Mariam and Yu, Nam-Kyung and Diedrich, Jolene K and Ma, Yuanhui and Wienand, Anne and McClatchy, Daniel B and Nykjaer, Anders and Nabavi, Sadegh and Yates, John R},
title = {DiDBiT-TMT: A Novel Method to Quantify Changes in the Proteomic Landscape Induced by Neural Plasticity},
journal = {Journal of Proteome Research},
year = {2024},
doi = {10.1021/acs.jproteome.4c00180}
}
EUVIMED